PURPOSE: We identified and validated [(18)F]-CP18, a DEVD (the caspase 3 substrate recognition motif) containing substrate-based compound as an imaging tracer for caspase-3 activity in apoptotic cells. PROCEDURES: CP18 was radiolabeled with fluorine-18 using click chemistry. The affinity and selectivity of CP18 for caspase-3 were evaluated in vitro. The biodistribution and metabolism pattern of [(18)F]-CP18 were assessed in vivo. [(18)F]-CP18 positron emission tomography (PET) scans were performed in a dexamethasone-induced thymic apoptosis mouse model. After imaging, the mice were sacrificed, and individual organs were collected, measured in a gamma counter, and tested for caspase-3 activity. RESULTS: In vitro enzymatic caspase-3 assay demonstrated specific cleavage of CP18. In vivo, [(18)F]-CP18 is predominantly cleared through the kidneys and urine, and is rapidly eliminated from the bloodstream. There was a sixfold increase in caspase activity and a fourfold increase of [(18)F]-CP18 retention in the dexamethasone-induced thymus of treated versus control mice. CONCLUSIONS: We report the use [(18)F]-CP18 as a PET tracer for imaging apoptosis. Our data support further development of this tracer for clinical PET applications.
PURPOSE: We identified and validated [(18)F]-CP18, a DEVD (the caspase 3 substrate recognition motif) containing substrate-based compound as an imaging tracer for caspase-3 activity in apoptotic cells. PROCEDURES: CP18 was radiolabeled with fluorine-18 using click chemistry. The affinity and selectivity of CP18 for caspase-3 were evaluated in vitro. The biodistribution and metabolism pattern of [(18)F]-CP18 were assessed in vivo. [(18)F]-CP18 positron emission tomography (PET) scans were performed in a dexamethasone-induced thymic apoptosis mouse model. After imaging, the mice were sacrificed, and individual organs were collected, measured in a gamma counter, and tested for caspase-3 activity. RESULTS: In vitro enzymatic caspase-3 assay demonstrated specific cleavage of CP18. In vivo, [(18)F]-CP18 is predominantly cleared through the kidneys and urine, and is rapidly eliminated from the bloodstream. There was a sixfold increase in caspase activity and a fourfold increase of [(18)F]-CP18 retention in the dexamethasone-induced thymus of treated versus control mice. CONCLUSIONS: We report the use [(18)F]-CP18 as a PET tracer for imaging apoptosis. Our data support further development of this tracer for clinical PET applications.
Authors: J Hickson; S Ackler; D Klaubert; J Bouska; P Ellis; K Foster; A Oleksijew; L Rodriguez; S Schlessinger; B Wang; D Frost Journal: Cell Death Differ Date: 2010-01-08 Impact factor: 15.828
Authors: F G Blankenberg; P D Katsikis; J F Tait; R E Davis; L Naumovski; K Ohtsuki; S Kopiwoda; M J Abrams; M Darkes; R C Robbins; H T Maecker; H W Strauss Journal: Proc Natl Acad Sci U S A Date: 1998-05-26 Impact factor: 11.205
Authors: Quang-Dé Nguyen; Graham Smith; Matthias Glaser; Meg Perumal; Erik Arstad; Eric O Aboagye Journal: Proc Natl Acad Sci U S A Date: 2009-09-03 Impact factor: 11.205
Authors: Gerrit J Kemerink; Xuan Liu; Davy Kieffer; Sarah Ceyssens; Luc Mortelmans; Alfons M Verbruggen; Neil D Steinmetz; Jean-Luc Vanderheyden; Allan M Green; Kristin Verbeke Journal: J Nucl Med Date: 2003-06 Impact factor: 10.057
Authors: Bin Shen; Jongho Jeon; Mikael Palner; Deju Ye; Adam Shuhendler; Frederick T Chin; Jianghong Rao Journal: Angew Chem Int Ed Engl Date: 2013-07-23 Impact factor: 15.336
Authors: Sara Rapic; Christel Vangestel; Filipe Elvas; Jeroen Verhaeghe; Tim Van den Wyngaert; Leonie Wyffels; Patrick Pauwels; Steven Staelens; Sigrid Stroobants Journal: Mol Imaging Biol Date: 2017-08 Impact factor: 3.488
Authors: Helen Su; Natalia Gorodny; Luis Felipe Gomez; Umesh Gangadharmath; Fanrong Mu; Gang Chen; Joseph C Walsh; Katrin Szardenings; Hartmuth C Kolb; Balaji Tamarappoo Journal: Circ Cardiovasc Imaging Date: 2015-02 Impact factor: 7.792
Authors: Matthew R Hight; Yiu-Yin Cheung; Michael L Nickels; Eric S Dawson; Ping Zhao; Samir Saleh; Jason R Buck; Dewei Tang; M Kay Washington; Robert J Coffey; H Charles Manning Journal: Clin Cancer Res Date: 2014-02-26 Impact factor: 12.531
Authors: Emre Demirci; Rafay Ahmed; Meltem Ocak; Joseph Latoche; April Radelet; Nicole DeBlasio; N Scott Mason; Carolyn J Anderson; James M Mountz Journal: Mol Imaging Date: 2017-01-01 Impact factor: 4.488
Authors: Anna A Rybczynska; Hendrikus H Boersma; Steven de Jong; Jourik A Gietema; Walter Noordzij; Rudi A J O Dierckx; Philip H Elsinga; Aren van Waarde Journal: Med Res Rev Date: 2018-03-12 Impact factor: 12.944